Haemonetics (NYSE:HAE) announced today that it plans to sell certain blood donor management software assets to the GPI Group.
GPI, a provider of IT solutions for healthcare and social services, is purchasing the assets from within Haemonetics’ blood center business unit, according to a news release.
Under the agreement, Boston-based Haemonetics and its subsidiary Global Med Technologies will transfer intellectual property, customer contracts and other assets relating to its ElDorado Donor, Hemasphere, Donor Doc, Donor Doc Phlebotomy, eDonor, DonorSpace, Surround and SafeTrace software products to GPI. GPI manages its U.S. business through its Hemasoft subsidiary, which specializes in web-based software for blood donor centers, blood banks, transfusion services, cell therapy labs and tissue banks.
Haemonetics and GPI group expect the transaction to close in the second quarter in the calendar year 2020, subject to closing conditions.
“We are committed to reshaping our portfolio for sustainable growth and this sale will enable us to focus on our core capabilities while delivering quality products and services where we bring distinct value,” Haemonetics global blood center president Chad Nikel said
in the news release. “We will continue to invest across our business, execute our customer-centric strategies to strengthen our trajectory and develop innovative medical technologies that meaningfully advance healthcare.”
“Our priority is to deliver state-of-the-art technology solutions with a comprehensive approach to cover all aspects of blood transfusion for maximum traceability, patient safety and high client satisfaction,” added GPI president & CEO Fausto Manzana. “GPI will merge the acquired assets with its U.S.-based Hemasoft operations to strengthen the Hemasoft presence in the U.S. by offering a complete portfolio of software and services.”